Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687
Dementia l: Introduction01:22

Dementia l: Introduction

33
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
33
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

996
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
996
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Speech-In-Noise Perception in Alzheimer's Disease and Primary Progressive Aphasia.

European journal of neurology·2026
Same author

Sarcopenic Obesity and Risk of Incident Type 2 Diabetes: A Prospective Cohort Study and Landmark Analysis From the UK Biobank.

Diabetes care·2026
Same author

Knowledge of inorganic nitrate dietary survey-2 (KINDS-2): a multinational cross-sectional study of nitrate knowledge, beliefs and purchasing behaviours in the general population and healthcare professionals.

International journal of food sciences and nutrition·2026
Same author

Attitudes Towards Brain Health and Dementia Risk Reduction Among Minoritised Ethnic Communities in the United Kingdom: A Cross-Sectional Survey Analysis.

International journal of geriatric psychiatry·2026
Same author

Recruitment strategies in a diverse Parkinson's disease cohort: lessons from the East London Parkinson's Disease Project.

BMJ neurology open·2026
Same author

Population-level interventions for dementia prevention: a systematic review.

The lancet. Healthy longevity·2026

Related Experiment Video

Updated: Apr 30, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

The principles of Population-Level Approaches to Dementia Risk Reduction (PLADRR).

Sebastian Walsh1, Susanne Röhr2,3, Joaquin Mígeot3,4

  • 1Cambridge Public Health, Hershel Smith Building, University of Cambridge, Cambridge, United Kingdom.

Plos Medicine
|April 28, 2026
PubMed
Summary

Dementia cases are rising globally, but population-level strategies can reduce risk. The Population-Level Approaches to Dementia Risk Reduction (PLADRR) Research Group aims to lower dementia incidence through policy and environmental changes.

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

6.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K

Related Experiment Videos

Last Updated: Apr 30, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

6.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K

Area of Science:

  • Public Health
  • Epidemiology
  • Gerontology

Background:

  • Dementia presents a significant global health policy challenge, with projected tripling of cases by 2050, especially in low- and middle-income nations.
  • Epidemiological data indicate declining age-specific dementia incidence rates in high-income countries, suggesting potential for population-level risk reduction.
  • Understanding modifiable risk factors is crucial for developing effective public health interventions.

Purpose of the Study:

  • To outline the guiding principles and research priorities of the Population-Level Approaches to Dementia Risk Reduction (PLADRR) Research Group.
  • To investigate how structural, social, and environmental factors influence life course brain health and dementia risk.
  • To translate research findings into actionable policy changes for dementia risk reduction.

Main Methods:

  • Establishing an international research network (PLADRR) comprising diverse experts.
  • Focusing on population-level interventions rather than individual-level approaches.
  • Analyzing structural, social, and environmental determinants of brain health across the lifespan.

Main Results:

  • Evidence suggests that population-level interventions can effectively lower dementia incidence.
  • Identifying key building blocks and research priorities for PLADRR initiatives.
  • Demonstrating the feasibility of translating research into policy for dementia prevention.

Conclusions:

  • Population-level strategies are essential for mitigating the growing dementia epidemic.
  • The PLADRR framework provides a roadmap for international collaboration in dementia risk reduction.
  • Policy changes informed by research can promote brain health and reduce dementia risk across diverse populations.